Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma
ACS Nano · 07.10.2025 · 19 (39) · 34659-34676
DOI: 10.1021/acsnano.5c08326 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 22.09.2025. Verfasst von Taian Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China. Hauptthemen laut MEDLINE: Sorafenib, Liver Neoplasms, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Administration of Chinese Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China.
- Intensive Care Research Team of Traditional Chinese Medicine, Guangdong Province Academy of Chinese Medicine, Guangzhou 510006, P. R. China.
- School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P. R. China.
- Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, P. R. China.
ORCID-Profile: Youyong Yuan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong Administration of Chinese Medicine
- Science and Technology Program of Guangzhou
- High Level Construction Foundation of Guangzhou University of Chinese Medicine
- Guangzhou Science and Technology Planning Project
- State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation
Zitieren
APA
Lin, T., Hou, Y., Liu, X., Ullah, I., Qiu, S., Lu, Z., Qi, J., & Yuan, Y. (2025). Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma. ACS Nano, 19(39), 34659-34676. https://doi.org/10.1021/acsnano.5c08326
Vancouver
Lin T, Hou Y, Liu X, Ullah I, Qiu S, Lu Z, et al. Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma. ACS Nano. 2025;19(39):34659-34676. doi:10.1021/acsnano.5c08326
BibTeX
@article{Lin2025,
author = {Lin, Taian and Hou, Yixuan and Liu, Xueqing and Ullah, Ihsan and Qiu, Siyu and Lu, Zidong and Qi, Jianyong and Yuan, Youyong},
title = {Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {39},
pages = {34659--34676},
doi = {10.1021/acsnano.5c08326}
}
EUVIMED